These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 23458461)

  • 1. The treatment of depressive disorders in epilepsy: what all neurologists should know.
    Kanner AM
    Epilepsia; 2013 Mar; 54 Suppl 1():3-12. PubMed ID: 23458461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Most antidepressant drugs are safe for patients with epilepsy at therapeutic doses: A review of the evidence.
    Kanner AM
    Epilepsy Behav; 2016 Aug; 61():282-286. PubMed ID: 27236241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of antidepressants on seizure frequency and depressive and anxiety disorders of patients with epilepsy: Is it worth investigating?
    Ribot R; Ouyang B; Kanner AM
    Epilepsy Behav; 2017 May; 70(Pt A):5-9. PubMed ID: 28407526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of anxiety disorders in epilepsy: an evidence-based approach.
    Mula M
    Epilepsia; 2013 Mar; 54 Suppl 1():13-8. PubMed ID: 23458462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Marson AG; Nevitt SJ
    Cochrane Database Syst Rev; 2021 Apr; 4(4):CD010682. PubMed ID: 33860531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antidepressant therapy in epilepsy: can treating the comorbidities affect the underlying disorder?
    Cardamone L; Salzberg MR; O'Brien TJ; Jones NC
    Br J Pharmacol; 2013 Apr; 168(7):1531-54. PubMed ID: 23146067
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Should antidepressant drugs of the selective serotonin reuptake inhibitor family be tested as antiepileptic drugs?
    Hamid H; Kanner AM
    Epilepsy Behav; 2013 Mar; 26(3):261-5. PubMed ID: 23395350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy.
    Blumer D
    J Clin Psychiatry; 1997 Jan; 58(1):3-11. PubMed ID: 9055830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Other Antidepressants.
    Schwasinger-Schmidt TE; Macaluso M
    Handb Exp Pharmacol; 2019; 250():325-355. PubMed ID: 30194544
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of depression with associated anxiety: comparisons of tricyclic antidepressants and selective serotonin reuptake inhibitors.
    Montgomery SA; Judge R
    Acta Psychiatr Scand Suppl; 2000; 403():9-16. PubMed ID: 11019930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multinational pharmacoeconomic evaluation of acute major depressive disorder (MDD): a comparison of cost-effectiveness between venlafaxine, SSRIs and TCAs.
    Doyle JJ; Casciano J; Arikian S; Tarride JE; Gonzalez MA; Casciano R
    Value Health; 2001; 4(1):16-31. PubMed ID: 11704969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antidepressants for people with epilepsy and depression.
    Maguire MJ; Weston J; Singh J; Marson AG
    Cochrane Database Syst Rev; 2014 Dec; 2014(12):CD010682. PubMed ID: 25464360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of adjunctive use of aripiprazole with bupropion or selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors: analysis of patients beginning adjunctive treatment in a 52-week, open-label study.
    Clayton AH; Baker RA; Sheehan JJ; Cain ZJ; Forbes RA; Marler SV; Marcus R; Berman RM; Thase ME
    BMC Res Notes; 2014 Jul; 7():459. PubMed ID: 25037144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of medical and psychological treatment of depression in patients with COPD--a review.
    Fritzsche A; Clamor A; von Leupoldt A
    Respir Med; 2011 Oct; 105(10):1422-33. PubMed ID: 21680167
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of selective serotonin reuptake inhibitors versus tricyclic antidepressants on cerebrovascular events: a nationwide population-based cohort study.
    Lee YC; Lin CH; Lin MS; Lin JW; Chang CH; Lai MS
    J Clin Psychopharmacol; 2013 Dec; 33(6):782-9. PubMed ID: 24091857
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Contemporary management of depression.
    Andrews JM; Nemeroff CB
    Am J Med; 1994 Dec; 97(6A):24S-32S. PubMed ID: 7992823
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antidepressant and tolerance: Determinants and management of major side effects].
    David DJ; Gourion D
    Encephale; 2016 Dec; 42(6):553-561. PubMed ID: 27423475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Efficacy of atypical antipsychotics in depressive syndromes].
    Quintin P; Thomas P
    Encephale; 2004; 30(6):583-9. PubMed ID: 15738862
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are antidepressant drugs that combine serotonergic and noradrenergic mechanisms of action more effective than the selective serotonin reuptake inhibitors in treating major depressive disorder? A meta-analysis of studies of newer agents.
    Papakostas GI; Thase ME; Fava M; Nelson JC; Shelton RC
    Biol Psychiatry; 2007 Dec; 62(11):1217-27. PubMed ID: 17588546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of antidepressant drugs in dermatology.
    Gupta MA; Guptat AK
    J Eur Acad Dermatol Venereol; 2001 Nov; 15(6):512-8. PubMed ID: 11843209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.